Loading...
ROCO
4745
Market cap47mUSD
Nov 12, Last price  
19.10TWD
Name

Cowealth Medical Holding Co Ltd

Chart & Performance

D1W1MN
ROCO:4745 chart
P/E
2,351.82
P/S
0.35
EPS
0.01
Div Yield, %
2.09%
Shrs. gr., 5y
Rev. gr., 5y
7.34%
Revenues
4.19b
-12.88%
4,721,939,0005,139,748,0005,626,367,0004,812,569,0004,192,722,000
Net income
629k
-98.87%
124,394,000139,464,00094,115,00055,709,000629,000
CFO
374m
+730.64%
0804,755,000-118,377,000-267,591,00045,022,000373,971,000
Dividend
Jun 27, 20240.4 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Cowealth Medical Holding Co., Ltd. operates in healthcare distribution sector in China. The company engages in the procurement, distribution, and management of reagents and consumables for medical institutions; and provides specialists to assist clients for inventory control, demand forecasting, departmental training, and application of information technology. It also offers integrated decision-making and analysis platform to support sophisticated hospital management; CyberKnife, a cutting-edge radiation oncology therapy; LipiView-LipiFlow, an ophthalmology technology; and MRIdian-Linac, an MRI-guided radiation therapy system. Cowealth Medical Holding Co., Ltd. was founded in 1997 and is based in Shanghai, China.
IPO date
Apr 12, 2013
Employees
Domiciled in
KY
Incorporated in
KY

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT